IMCY-0098 Proof of ACtion in Type 1 Diabetes (IMPACT Study)

IMCY-0098 Proof of ACtion in Type 1 Diabetes (IMPACT Study)
Condition:   Diabetes Mellitus, Type 1
Interventions:   Drug: IMCY-0098 450 μg;   Drug: IMCY-0098 1350 μg;   Drug: Placebo
Sponsor:   Imcyse SA
**RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

July 13, 2022Comments OffClinicalTrials.gov | Endocrinology Clinical Trials | Endocrinology Studies | US National Library of Medicine
Comments